Showing results (931-940 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 8, 2007
Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumorsRaushan T Kurmasheva, Franklin C Harwood, Peter J Houghton
Molecular Cancer Therapeutics|July 30, 2009
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell deathChangyou Li, Yan Zang, Malabika Sen, et al.
Molecular Cancer Therapeutics|October 1, 2009
Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effectWoo Hyung Lee, Young Woo Kim, Jae Hoon Choi, et al.
Molecular Cancer Therapeutics|September 3, 2009
Chemokine CXC receptor 4--mediated glioma tumor tracking by bone marrow--derived neural progenitor/stem cellsQijin Xu, Xiangpeng Yuan, Minlin Xu, et al.
Molecular Cancer Therapeutics|September 3, 2009
A novel target for treatment of chordoma: signal transducers and activators of transcription 3Cao Yang, Joseph H Schwab, Andrew J Schoenfeld, et al.
Molecular Cancer Therapeutics|September 3, 2009
Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokinesMatthew A Bill, Courtney Bakan, Don M Benson, et al.
Molecular Cancer Therapeutics|September 3, 2009
AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancerShu Yang, Van Chanh Ngo, Guo Bin Lew, et al.
Molecular Cancer Therapeutics|September 3, 2009
Modulation of transcription by the peroxisome proliferator-activated receptor delta--binding RNA aptamer in colon cancer cellsHoyun Kwak, Injoo Hwang, Jee Ho Kim, et al.
Molecular Cancer Therapeutics|September 3, 2009
An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalentlyJulien Viaud, Jeffrey R Peterson
Molecular Cancer Therapeutics|September 3, 2009
Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myelomaFrits van Rhee, Susann M Szmania, Myles Dillon, et al.
Pageof 599